Literature DB >> 1972378

Differential transport properties of two mdr gene products are distinguished by progesterone.

C P Yang1, D Cohen, L M Greenberger, S I Hsu, S B Horwitz.   

Abstract

P-glycoprotein is an integral membrane protein that is overproduced in multidrug-resistant cells. It is likely to function as an energy-dependent drug efflux pump to maintain intracellular drug concentrations below cytotoxic levels. Individually isolated multidrug-resistant murine cell lines, J7.V1-1 and J7.V3-1, overproduce P-glycoproteins encoded by the mdr1b and mdr1a genes, respectively. The transport properties of these cell lines and the drug binding characteristics of their P-glycoproteins have been compared. It is concluded that 1) the mdr1a gene product is a more efficient efflux pump than the mdr1b gene product, and 2) whereas a single class of vinblastine binding sites is present in J7.V1-1 membrane vesicles, there appears to be two classes of such sites in J7.V3-1 membrane vesicles. The effects of verapamil and progesterone, two compounds that are known to interact with P-glycoprotein, have been analyzed in the two cell lines. Progesterone inhibited drug binding and efflux and increased drug sensitivity to vinblastine with more potency in J7.V1-1 cells than in J7.V3-1 cells. It is concluded that progesterone, but not verapamil, can be used to differentiate the two mdr gene products in the mouse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972378

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins.

Authors:  Guido J E J Hooiveld; Janette Heegsma; Jessica E van Montfoort; Peter L M Jansen; Dirk K F Meijer; Michael Müller
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

2.  A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.

Authors:  P Gros; R Dhir; J Croop; F Talbot
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

3.  Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes.

Authors:  E Buschman; P Gros
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

4.  The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease.

Authors:  M A Valverde; T D Bond; S P Hardy; J C Taylor; C F Higgins; J Altamirano; F J Alvarez-Leefmans
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

Review 5.  Using purified P-glycoprotein to understand multidrug resistance.

Authors:  A B Shapiro; V Ling
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

6.  Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.

Authors:  S Orlowski; L M Mir; J Belehradek; M Garrigos
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 7.  Multidrug resistance in cancer chemotherapy.

Authors:  N H Patel; M L Rothenberg
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

8.  Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.

Authors:  L Wang; C P Yang; S B Horwitz; P A Trail; A M Casazza
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 9.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

10.  Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein.

Authors:  G F Fleming; J M Amato; M Agresti; A R Safa
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.